Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy-naive men with metastatic castration-resistant prostate cancer (COU-AA-302): final overall survival analysis of a randomised, double-blind, placebo-controlled phase 3 study
2015 ◽
Vol 16
(2)
◽
pp. 152-160
◽
2012 ◽
Vol 13
(10)
◽
pp. 983-992
◽
2019 ◽
Vol 20
(3)
◽
pp. 408-419
◽
2016 ◽
Vol 23
(5)
◽
pp. 404-411
◽
2017 ◽
Vol 35
(1)
◽
pp. 124-125
◽
2011 ◽
Vol 47
◽
pp. S483-S484
◽